David Steinberg

David Steinberg is the founder of Pyxis Oncology, Inc., serving as Chairman from 2019 to 2021, founded in 2018.
Mr. Steinberg was the founder of Vedanta Biosciences, Inc., serving as Director, founded in 2010.
Mr. Steinberg is the founder of Enlight Biosciences LLC, serving as Director, founded in 2008.
Mr. Steinberg is also the founder of Be Biopharma, Inc.,Photys Therapeutics, Inc. Mr. Steinberg is currently a Director at Carbon Biosciences, Inc. Mr. Steinberg is currently a Director at Commense, Inc. Mr. Steinberg is currently a Director at Rectify Pharmaceuticals LLC.
Mr. Steinberg is currently a General Partner at Longwood Fund Management LLC, starting in 2019.
Mr. Steinberg is currently the Chief Business Officer at Follica, Inc., starting in 2006.
Former positions include Acting Chief Executive Officer at ENDRA Life Sciences, Inc. from 2009 to 2011.
Former positions include Chief Executive Officer & Director at IMRSV, Inc. Former positions include Director at Entrega, Inc. Former positions include Independent Director at resTORbio, Inc. from 2017 to 2020.
Former positions include President, Secretary, Treasurer & Director at Knode, Inc. Former positions include Director at Vor Biopharma, Inc. Former positions include Consultant at Vertex Partners.
Former positions include Associate at Procter & Gamble Co. Former positions include Consultant at The Boston Consulting Group, Inc. Former positions include Vice President-Operations at Satori Pharmaceuticals, Inc. Former positions include Chief Innovation Officer at PureTech Health Plc from 2002 to 2018.
Former positions include Partner at PureTech Health LLC.
Education includes an MBA from The University of Chicago Booth School of Business.
Education includes an undergraduate degree from Cornell University.